Análisis de la cuota de mercado y oportunidades de diagnóstico de infecciones hospitalarias (2025-2031)
Hospital Acquired Infections Diagnostics Market Report Analysis
Hospital Acquired Infections Diagnostics Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million

Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Abbott Laboratories
- AdvanDX
- Alere Inc.
- AstraZeneca Plc
- Becton Dickinson and Company
- Hologic, Inc
- Bayer Schering Pharma LLC
- Cepheid Inc
- Roche AG
Regional Overview

- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
- Medio Oriente y África
Market Segmentation

- Instrumento y Reactivos
- Consumibles

- diagnóstico molecular
- análisis de orina
- inmunoensayo

- pruebas de enfermedades
- pruebas de resistencia a los medicamentos

- neumonía adquirida en el hospital
- infecciones del torrente sanguíneo
- infecciones del sitio quirúrgico
- infecciones gastrointestinales
- otras